APA (7th ed.) Citation

Lin, D. S., Yu, A., Lo, H., Lien, C., Lee, J., & Chen, W. (2022). Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors. Diabetologia, 65(12), 2032-2043. https://doi.org/10.1007/s00125-022-05772-9

Chicago Style (17th ed.) Citation

Lin, Donna Shu-Han, An-Li Yu, Hao-Yun Lo, Cheng-Wei Lien, Jen-Kuang Lee, and Wen-Jone Chen. "Major Adverse Cardiovascular and Limb Events in People with Diabetes Treated with GLP-1 Receptor Agonists Vs SGLT2 Inhibitors." Diabetologia 65, no. 12 (2022): 2032-2043. https://doi.org/10.1007/s00125-022-05772-9.

MLA (9th ed.) Citation

Lin, Donna Shu-Han, et al. "Major Adverse Cardiovascular and Limb Events in People with Diabetes Treated with GLP-1 Receptor Agonists Vs SGLT2 Inhibitors." Diabetologia, vol. 65, no. 12, 2022, pp. 2032-2043, https://doi.org/10.1007/s00125-022-05772-9.